Skip to main content

Carrie Mendivil

Head of Investor Relations

Adaptive Biotechnologies Corp (ADPT)

Head of Investor Relations

10x Genomics, Inc. (TXG)

Head of Investor Relations

Guardant Health, Inc. (GH)

Head of Investor Relations

908 Devices Inc. (MASS)

Head of Investor Relations

Seer, Inc. (SEER)

Head of Investor Relations

Nautilus Biotechnology, Inc. (NAUT)

Head of Investor Relations

Ginkgo Bioworks Holdings, Inc. (DNA)

Head of Investor Relations

SI-BONE, Inc. (SIBN)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Carrie Mendivil

Carrie Mendivil is recorded as Head of Investor Relations at Adaptive Biotechnologies Corp (ADPT), Head of Investor Relations at 10x Genomics, Inc. (TXG), Head of Investor Relations at Guardant Health, Inc. (GH), Head of Investor Relations at Pacific Biosciences Of California, Inc. (PACB), Head of Investor Relations at 908 Devices Inc. (MASS), Head of Investor Relations at Seer, Inc. (SEER), Head of Investor Relations at Nautilus Biotechnology, Inc. (NAUT), Head of Investor Relations at Ginkgo Bioworks Holdings, Inc. (DNA) and Head of Investor Relations at SI-BONE, Inc. (SIBN). Carrie Mendivil has spoken on 29 earnings calls across 4 companies, most recently for Seer, Inc. on February 27, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Seer, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Guardant Health, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Nautilus Biotechnology, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 17 earlier activities